Ching Kong Loo

559 total citations
8 papers, 193 citations indexed

About

Ching Kong Loo is a scholar working on Epidemiology, Genetics and Hepatology. According to data from OpenAlex, Ching Kong Loo has authored 8 papers receiving a total of 193 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 3 papers in Genetics and 3 papers in Hepatology. Recurrent topics in Ching Kong Loo's work include Microscopic Colitis (3 papers), Hepatitis C virus research (3 papers) and Inflammatory Bowel Disease (3 papers). Ching Kong Loo is often cited by papers focused on Microscopic Colitis (3 papers), Hepatitis C virus research (3 papers) and Inflammatory Bowel Disease (3 papers). Ching Kong Loo collaborates with scholars based in China, Hong Kong and United Kingdom. Ching Kong Loo's co-authors include Luca Raiteri, M Chan, Kwok Sang Yee, Aric J. Hui, Michael K. K. Li, A. M.‐L. Chim, Siu Yin Wong, Grace Lai–Hung Wong, Sik To Lai and Ting Kin Cheung and has published in prestigious journals such as Gastroenterology, CHEST Journal and Journal of Gastroenterology.

In The Last Decade

Ching Kong Loo

7 papers receiving 184 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ching Kong Loo China 6 113 45 38 31 23 8 193
Jill Cooke United Kingdom 6 43 0.4× 35 0.8× 25 0.7× 20 0.6× 35 1.5× 9 148
Gowrie Balasubramaniam United Kingdom 7 82 0.7× 26 0.6× 14 0.4× 20 0.6× 155 6.7× 16 290
Kwok Sang Yee China 7 230 2.0× 104 2.3× 14 0.4× 54 1.7× 13 0.6× 10 293
K. Viel Germany 10 336 3.0× 287 6.4× 13 0.3× 14 0.5× 12 0.5× 14 393
Tongyu Zhu China 9 46 0.4× 25 0.6× 50 1.3× 5 0.2× 70 3.0× 20 209
Riccardo Pela Italy 9 255 2.3× 122 2.7× 32 0.8× 47 1.5× 23 1.0× 18 310
Carmen Cobelo Spain 8 23 0.2× 10 0.2× 22 0.6× 13 0.4× 23 1.0× 15 174
Raquel Alegre Spain 5 63 0.6× 11 0.2× 11 0.3× 4 0.1× 36 1.6× 8 172
Janine Bullard United States 7 318 2.8× 18 0.4× 15 0.4× 9 0.3× 202 8.8× 9 446
Tomonari Ogawa Japan 6 28 0.2× 25 0.6× 17 0.4× 27 0.9× 36 1.6× 32 145

Countries citing papers authored by Ching Kong Loo

Since Specialization
Citations

This map shows the geographic impact of Ching Kong Loo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching Kong Loo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching Kong Loo more than expected).

Fields of papers citing papers by Ching Kong Loo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching Kong Loo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching Kong Loo. The network helps show where Ching Kong Loo may publish in the future.

Co-authorship network of co-authors of Ching Kong Loo

This figure shows the co-authorship network connecting the top 25 collaborators of Ching Kong Loo. A scholar is included among the top collaborators of Ching Kong Loo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching Kong Loo. Ching Kong Loo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Loo, Ching Kong, et al.. (2021). Diagnostic accuracy of fecal calprotectin in predicting significant gastrointestinal diseases. JGH Open. 5(6). 647–652. 9 indexed citations
2.
Yip, Terry Cheuk‐Fung, Grace Lai–Hung Wong, Yee‐Kit Tse, et al.. (2020). High incidence of hepatocellular carcinoma and cirrhotic complications in patients with psychiatric illness: a territory-wide cohort study. BMC Gastroenterology. 20(1). 128–128. 4 indexed citations
3.
Chan, Henry Lik‐Yuen, Aric J. Hui, Michael K. K. Li, et al.. (2018). Switching to peginterferon for chronic hepatitis B patients with hepatitis B e antigen seroconversion on entecavir – A prospective study. Journal of Viral Hepatitis. 26(1). 126–135. 19 indexed citations
4.
So, Jacqueline, Whitney Tang, Francis K.L. Chan, et al.. (2017). 5-Aminosalicylic Acid and Statin use are Associated with Reduced Risk of Cancers in Patients with Inflammatory Bowel Disease: A Population-Based Cohort Study. Gastroenterology. 152(5). S373–S373.
5.
Ko, Michael, Siew C. Ng, Lung‐Yi Mak, et al.. (2016). Infection‐related hospitalizations in the first year after inflammatory bowel disease diagnosis. Journal of Digestive Diseases. 17(9). 610–617. 11 indexed citations
6.
Raiteri, Luca, et al.. (2013). High-Dose N-Acetylcysteine in Stable COPD. CHEST Journal. 144(1). 106–118. 124 indexed citations
7.
Chan, Pierre, Ching Kong Loo, Ting Kin Cheung, et al.. (2008). Management and outcome of peptic ulcers or erosions in patients receiving a combination of aspirin plus clopidogrel. Journal of Gastroenterology. 43(9). 679–686. 18 indexed citations
8.
Hui, Pak K., et al.. (2002). Hepatitis B associated fulminant polyarteritis nodosa: successful treatment with pulse cyclophosphamide, prednisolone and lamivudine following emergency surgery. European Journal of Gastroenterology & Hepatology. 14(5). 563–566. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026